CDKN2B and neoplasm: Tumor-suppressor genes involved in cellular proliferation and the DNA damage response were mutated at a high frequency and included CDKN2A (51%), CDKN2B (23%), BTG2 (28%), BTG1 (23%), and TP53 (34%).